Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-16.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Jul 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| WuXi Biologics Ireland Limited | 16 Dec 2025 | Human Drugs | On file |
| Ten23 Health Valais AG | 27 Aug 2025 | Human Drugs | On file |
| Shanghai Henlius Biologics Co., Ltd. | 11 Mar 2025 | Human Drugs | On file |
| Nang Kuang Pharmaceutical Co. Ltd. | 7 Nov 2024 | Human Drugs | On file |
| F. Hoffmann-La Roche AG | 4 Nov 2024 | Human Drugs | On file |
Sites inspected
WuXi Biologics Ireland LimitedDundalk, Ireland1 insp.
Ten23 Health Valais AGVisp, Switzerland1 insp.
Shanghai Henlius Biologics Co., Ltd.Shanghai, China1 insp.
Nang Kuang Pharmaceutical Co. Ltd.Tainan City, Taiwan1 insp.
F. Hoffmann-La Roche AGKaiseraugst, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen3 shared
Sudipan Karmakar2 shared
Bo Chi2 shared
Dilip D Devineni1 shared
Qiao Y Bobo1 shared
Karthik M Krishnan1 shared
Mia J Chang1 shared
Gerald M Feldman1 shared
Reyes Candau-Chacon1 shared
Full investigator report
Get the verbatim findings behind Liqun Zhao's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site